New clinical trial registered: Shanghai UniXell Biotechnology have initiated a Phase 1 open-label, dose-escalation &amp; dose-expansion exploratory clinical study evaluating safety &amp; tolerability of UX-DA001 in idiopathic #Parkinsons
#Parkinsons